"There has been an extended-standing need to have for additional helpful treatments for treatment-resistant depression, a significant and life-threatening issue," explained Tiffany Farchione, M.D., acting director with the Division of Psychiatry Solutions within the FDA's Center for Drug Evaluation and Research. "Managed clinical trials that examined the safety and efficacy https://elliottxhsry.vidublog.com/26326236/the-5-second-trick-for-ketamine-s-for-depression-reviews